You are not logged in.
This means you
CAN ONLY VIEW reports that were published prior to Saturday, October 19, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
AFTER MARKET UPDATE - MONDAY, DECEMBER 29TH, 2014
Previous After Market Report Next After Market Report >>>
|
|
|
|
DOW |
-15.48 |
18,038.23 |
-0.09% |
|
Volume |
538,354,750 |
+24% |
|
Volume |
1,145,254,150 |
+32% |
|
NASDAQ |
+0.05 |
4,806.91 |
+0.00% |
|
Advancers |
1,818 |
57% |
|
Advancers |
1,471 |
51% |
|
S&P 500 |
+1.80 |
2,090.57 |
+0.09% |
|
Decliners |
1,307 |
41% |
|
Decliners |
1,341 |
46% |
|
Russell 2000 |
+3.90 |
1,219.11 |
+0.32% |
|
52 Wk Highs |
253 |
|
|
52 Wk Highs |
158 |
|
|
S&P 600 |
+2.80 |
702.66 |
+0.40% |
|
52 Wk Lows |
36 |
|
|
52 Wk Lows |
43 |
|
|
 |
Major Averages Ended Mixed and Little Changed
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
On Monday's session the major indices ended mixed and little changed. The Dow fell 15 points to 18,038. The S&P 500 gained 1 point to 2,090. The NASDAQ finished virtually unchanged at 4,806. The volume totals on the NYSE and on the Nasdaq exchange were up from Friday's totals. Advancers led decliners by a 3-2 margin on the NYSE but the mix was nearly even on the Nasdaq exchange. There were 85 high-ranked companies from the CANSLIM.net Leaders List that made new 52-week highs and appeared on the CANSLIM.net BreakOuts Page, down from the prior session total of 88 stocks. New 52-week highs outnumbered new 52-week lows on the NYSE and on the Nasdaq exchange. There gains for 6 of the 10 high-ranked companies currently on the Featured Stocks Page, a list that has recently been getting trimmed.
New highs for the Dow Jones Industrial Average and S&P 500 Index, coupled with more leadership, signaled that the market (M criteria) is back in a confirmed uptrend. Remember that new buying efforts should only be made in stocks meeting all fundamental and technical guidelines of the fact-based investment system.
PICTURED: The Dow Jones Industrial Average paused at its all-time high after a streak of 6 consecutive gains.
The major averages toggled between gains and losses on Monday, as investors contended with weakness in Europe and falling oil prices. In Greece, Prime Minister Antonis Samaras failed to gather coalition support for his candidate, spurring speculation that an anti-austerity party may be able to seize control. Domestically, a reading of manufacturing activity in the Dallas Fed region surprisingly fell by the most in over a year.
At the close, six of the 10 sectors in the S&P 500 were in positive territory. Utilities were up the most, as NextEra Energy (NEE +1.1%) gained on positive analyst commentary. Despite a fall in oil prices, energy stocks also gained on the session as Marathon Petroleum (MPC +1.5%) rallied. Biotech was another bright spot. Gilead Sciences (GILD +3.7%) surged on reinvigorated partnerships. Tech stocks were relative underperformers, as Microsoft (MSFT -0.9%) and IBM (IBM -1.1%) lost ground.
Treasuries advanced, as the 10-year note climbed 12/32 to yield 2.21%. In commodities, WTI crude on the NYMEX erased earlier gains to finish -2% lower to $53.66/barrel. COMEX gold lost -1.1% to $1,181.70/ounce.
Disciplined investors know that new buying efforts should only be made in stocks when all fundamental and technical guidelines are met. This should be done as the stock is breaking out of a sound base pattern. Historic studies have shown that odds are not as favorable for investors when buying stocks on pullbacks.
The Featured Stocks Page shows recent notes and Headline Links directing members to detailed analysis with data-packed graphs annotated by a Certified expert. See the Premium Member Homepage for archives to all prior pay reports published.
|
Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. |
|
 |
Retail, Bank, Biotech, and Oil Services Indexes Rose
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The Retail Index ($RLX +0.79%) was a positive influence on the major averages on Monday. The Bank Index ($BKX +0.52%) also posted a modest gain, meanwhile the Broker/Dealer Index ($XBD -0.14%) ended the session with a small loss. The tech sector saw small losses for the Networking Index ($NWX -0.38%) and the Semiconductor Index ($SOX -0.28%) while the Biotechnology Index ($BTK +0.29%) eked out a small gain. The Oil Services Index ($OSX +0.69%) rose while the Integrated Oil Index ($XOI +0.05%) finished flat.The Gold & Silver Index ($XAU -2.51%) was a standout decliner.
Charts courtesy www.stockcharts.com
PICTURED: The Biotechnology Index ($BTK +0.29%) recently found support at its 50-day moving average (DMA) line.
| Oil Services |
$OSX |
215.45 |
+1.48 |
+0.69% |
-23.34% |
| Integrated Oil |
$XOI |
1,367.22 |
+0.74 |
+0.05% |
-9.04% |
| Semiconductor |
$SOX |
695.08 |
-1.92 |
-0.28% |
+29.91% |
| Networking |
$NWX |
363.42 |
-1.38 |
-0.38% |
+12.19% |
| Broker/Dealer |
$XBD |
186.44 |
-0.25 |
-0.14% |
+16.12% |
| Retail |
$RLX |
1,035.09 |
+8.13 |
+0.79% |
+10.14% |
| Gold & Silver |
$XAU |
66.68 |
-1.72 |
-2.51% |
-20.76% |
| Bank |
$BKX |
75.24 |
+0.39 |
+0.52% |
+8.63% |
| Biotech |
$BTK |
3,495.45 |
+9.99 |
+0.29% |
+49.99% |
|
|
|
 |
Formed New Base Above Prior Highs and 50-Day Moving Average
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Actavis plc (ACT +$3.13 or +1.22% to $260.22) found support above prior highs in the $249 area and above its 50-day moving average (DMA) line defining near-term support. A new pivot point was cited based on its high plus 10 cents. Subsequent volume -driven gains for new highs may trigger a new (or add-on) technical buy signal. It was last shown in this FSU section on 12/12/14 with annotated graphs under the headline, "Consolidating After Rally on Acquisition Plans", after spiking to new 52-week highs with volume-driven gains following news it plans to acquire Allergan (AGN) for $66 Billion.
ACT was first highlighted in yellow in the 6/20/14 mid-day report (read here) with a pivot point based on its 2/26/14 high plus 10 cents. The Medical - Generic Drugs industry group currently has an 81 Group Relative Strength Rating. Leadership from other issues in the group is also a reassuring sign concerning the L criteria. It reported earnings +53% on +83% sales revenues for the Sep '14 quarter, and its strong record satisfies the C criteria. Its annual earnings (A criteria) history has also been strong. The number of top-rated funds owning its shares has been on the rise, up from 1,219 in Sep '13 to 1,808 in Sep '14, and its Up/Down Volume ratio of 1.8 is an unbiased indication its shares have been under accumulation over the past 50 days, reassuring signs concerning the I criteria.
|
|
|
Color Codes Explained :
Y - Better candidates highlighted by our
staff of experts.
G - Previously featured
in past reports as yellow but may no longer be buyable under the
guidelines.
***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
ACT
-
NYSE
Actavis plc
Medical-Generic Drugs
|
$260.22
|
+3.13
1.22% |
$261.21
|
1,438,001
47.44% of 50 DAV
50 DAV is 3,031,000
|
$272.75
-4.59%
|
12/29/2014
|
$260.22
|
PP = $272.85
|
|
MB = $286.49
|
Most Recent Note - 12/29/2014 6:03:30 PM
Y - Color code is changed to yellow with new pivot point cited based on its 11/26/14 high plus 10 cents. Consolidating above support at prior highs and its 50 DMA line. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Formed New Base Above Prior Highs and 50-Day Moving Average - 12/29/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AFSI
-
NASDAQ
Amtrust Financial Svcs
INSURANCE - Property and; Casualty Insurance
|
$55.83
|
+1.53
2.82% |
$55.92
|
573,891
53.19% of 50 DAV
50 DAV is 1,079,000
|
$59.31
-5.87%
|
10/17/2014
|
$45.24
|
PP = $46.02
|
|
MB = $48.32
|
Most Recent Note - 12/24/2014 2:42:28 PM
G - Finding support near prior highs in the $53 area defining initial support above its 50 DMA line. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Finding Support Near Prior Highs - 12/24/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
ALXN
-
NASDAQ
Alexion Pharmaceuticals
DRUGS - Drug Manufacturers - Other
|
$188.71
|
+1.23
0.65% |
$189.43
|
862,774
77.38% of 50 DAV
50 DAV is 1,115,000
|
$203.30
-7.18%
|
10/23/2014
|
$184.01
|
PP = $185.53
|
|
MB = $194.81
|
Most Recent Note - 12/26/2014 5:53:33 PM
G - Rebounded with a quiet gain today ending near its 50 DMA line which may act as resistance. The recent low ($176.01 on 12/17/14) defines the next important support level. It faces resistance due to overhead supply up through $203. Disciplined investors limit losses by selling if any stock falls more than -7% from their purchase price.
>>> FEATURED STOCK ARTICLE : Recent 50-Day Moving Average Violation Triggered Sell Signal - 12/17/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
BIDU
-
NASDAQ
Baidu Inc Ads
INTERNET - Internet Information Providers
|
$230.21
|
-4.67
-1.99% |
$234.80
|
2,211,071
65.75% of 50 DAV
50 DAV is 3,363,000
|
$251.99
-8.64%
|
10/30/2014
|
$234.08
|
PP = $231.51
|
|
MB = $243.09
|
Most Recent Note - 12/23/2014 7:02:49 PM
Y - Color code is changed to yellow while quietly consolidating. Recent lows in the $217-218 area define important near-term support following its quiet rebound above its 50 DMA line.
>>> FEATURED STOCK ARTICLE : Rebound Above 50-Day Moving Average Helped Technical Stance - 12/19/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
EPAM
-
NYSE
Epam Systems Inc
COMPUTER SOFTWARE and SERVICES - Information Technology Service
|
$48.28
|
-0.56
-1.15% |
$48.66
|
340,355
76.31% of 50 DAV
50 DAV is 446,000
|
$52.89
-8.72%
|
10/23/2014
|
$45.21
|
PP = $46.09
|
|
MB = $48.39
|
Most Recent Note - 12/29/2014 6:05:25 PM
G - Still consolidating just above its 50 DMA line. Prior highs in the $46 area acted as support last week. Subsequent losses below recent lows would raise concerns and trigger a more worrisome technical sell signal.
>>> FEATURED STOCK ARTICLE : Violated 50-Day Moving Average Triggering Technical Sell Signal - 12/16/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
FB
-
NASDAQ
Facebook Inc Cl A
INTERNET
|
$80.02
|
-0.76
-0.93% |
$80.96
|
14,102,366
43.49% of 50 DAV
50 DAV is 32,429,000
|
$82.17
-2.62%
|
12/22/2014
|
$81.79
|
PP = $81.26
|
|
MB = $85.32
|
Most Recent Note - 12/29/2014 6:08:05 PM
Y - Holding its ground with volume totals cooling while perched at its all-time high and no resistance remains due to overhead supply. Volume-driven gains above the pivot point are needed to clinch a proper new (or add-on) technical buy signal.
>>> FEATURED STOCK ARTICLE : Gains for New Highs Backed By Lighter Volume - 12/22/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
ILMN
-
NASDAQ
Illumina Inc
DRUGS - Biotechnology
|
$189.53
|
+1.33
0.71% |
$189.88
|
621,697
52.60% of 50 DAV
50 DAV is 1,182,000
|
$197.37
-3.97%
|
10/22/2014
|
$188.77
|
PP = $182.27
|
|
MB = $191.38
|
Most Recent Note - 12/23/2014 6:54:59 PM
G - Ended below its 50 DMA line ($184.61) and near the session low with today's loss on below average volume. Only a prompt rebound above the 50 DMA line would help its outlook improve. Meanwhile it faces some resistance due to overhead supply up through $197.
>>> FEATURED STOCK ARTICLE : Violation of 50-Day Average Triggered Technical Sell Signal - 12/15/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
PANW
-
NYSE
Palo Alto Networks
Computer Sftwr-Security
|
$122.89
|
-4.54
-3.56% |
$127.18
|
1,655,773
103.29% of 50 DAV
50 DAV is 1,603,000
|
$128.20
-4.14%
|
7/30/2014
|
$84.21
|
PP = $85.88
|
|
MB = $90.17
|
Most Recent Note - 12/29/2014 12:35:40 PM
G - Pulling back today on slightly higher volume. Prior reports cautioned members - "It has not formed a sound base. The 50 DMA line defines near-term support to watch below recent lows."
>>> FEATURED STOCK ARTICLE : Latest Consolidation Was Not a Base of Sufficient Length - 12/18/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
RH
-
NYSE
Restoration Hardware Hld
RETAIL - Home Furnishing Stores
|
$97.94
|
+1.94
2.02% |
$98.49
|
509,413
55.37% of 50 DAV
50 DAV is 920,000
|
$100.66
-2.70%
|
12/11/2014
|
$98.66
|
PP = $94.60
|
|
MB = $99.33
|
Most Recent Note - 12/26/2014 5:55:25 PM
Y - Has been quietly consolidating below its "max buy" level. Subsequent losses leading to a close below its old high close ($93.05 on 6/30/14) would completely negate the recent breakout and raise concerns. See the latest FSU analysis fore more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Consolidating Above Prior Highs With Volume Totals Cooling - 12/26/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
UIHC
-
NASDAQ
United Insurance Holding
Insurance-Prop/Cas/Titl
|
$21.31
|
+0.18
0.85% |
$21.45
|
71,494
30.42% of 50 DAV
50 DAV is 235,000
|
$22.41
-4.91%
|
12/5/2014
|
$20.64
|
PP = $20.31
|
|
MB = $21.33
|
Most Recent Note - 12/23/2014 6:52:10 PM
G - Rose further above its "max buy" level as it posted a 7th consecutive gain. Disciplined investors avoid chasing stocks more than +5% above prior highs and always limit losses by selling any stock that falls more than -7% from its purchase price. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Recent Streak of Gains Lacked Volume Conviction - 12/23/2014
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
This site is not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307
or 954-785-1121.
|
|
|
